Human immunodeficiency virus (HIV) infection modifies the natural history of chronic hepatitis C, thus promoting more rapid progression to cirrhosis and end-stage liver disease. The objective of our study was to determine whether hepatitis C virus (HCV) clearance is associated with improved clinical
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy
β Scribed by M. E. MANCUSO; M. G. RUMI; A. AGHEMO; E. SANTAGOSTINO; M. PUOTI; A. COPPOLA; M. COLOMBO; P. M. MANNUCCI
- Book ID
- 109153104
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 273 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1538-7933
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe
## Abstract Limited evidence is available currently regarding the efficacy and safety of pegylated interferon (PEGβIFN) and ribavirin in patients coβinfected perinatally with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). No information is available on whether or not these patients
Anemia may increase the likelihood of achieving a sustained virological response (SVR) during pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) infection. To determine whether hemoglobin decline is associated with SVR, we retrospectively evaluated the CHARIOT study of 871 treat